Related Experiment Videos
Anticoagulation therapy for patients with atrial fibrillation
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Comparison of bleeding risk scores in patients with atrial fibrillation: insights from the RE-LY trial.
Journal of internal medicine·2017
Anemia predicts thromboembolic events, bleeding complications and mortality in patients with atrial fibrillation: insights from the RE-LY trial.
Journal of thrombosis and haemostasis : JTH·2015
Assessing the impact of dabigatran and warfarin on health-related quality of life: results from an RE-LY sub-study.
International journal of cardiology·2013
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation.
International journal of clinical practice·2013
Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.
Journal of thrombosis and haemostasis : JTH·2011
Defibrillation testing at the time of ICD insertion: an analysis from the Ontario ICD Registry.
Journal of cardiovascular electrophysiology·2010
Experiences of culturally Deaf people with health care access and navigation in Ontario, Canada: a qualitative co-design study.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Emergency physician burnout and attrition in Canada: a longitudinal study.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Fractional exhaled nitric oxide is a non-invasive disease activity marker of IgG4-related disease.
Rheumatology (Oxford, England)·2026
Coronary CT angiography-derived perivascular fat attenuation index as a potential marker for heart failure in hypertrophic cardiomyopathy.
The British journal of radiology·2026
One-Step Immobilized Phage Depolymerase Coatings for Catheter-Related Bloodstream Infections.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Inhibition of Dyrk1a attenuates type 1 diabetic cardiomyopathy via anti‑ferroptosis.
Molecular medicine reports·2026